Robeco Institutional Asset Management B.V. Raises Stock Position in Teladoc Health, Inc. (NYSE:TDOC)

Robeco Institutional Asset Management B.V. raised its position in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 21.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 700,166 shares of the health services provider's stock after acquiring an additional 125,111 shares during the period. Robeco Institutional Asset Management B.V. owned approximately 0.41% of Teladoc Health worth $6,365,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Bank of Montreal Can grew its position in shares of Teladoc Health by 470.6% during the 2nd quarter. Bank of Montreal Can now owns 94,466 shares of the health services provider's stock worth $926,000 after buying an additional 77,909 shares in the last quarter. Millennium Management LLC boosted its holdings in Teladoc Health by 11.8% in the second quarter. Millennium Management LLC now owns 409,669 shares of the health services provider's stock valued at $4,007,000 after purchasing an additional 43,260 shares during the last quarter. The Manufacturers Life Insurance Company grew its stake in shares of Teladoc Health by 195.3% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 95,307 shares of the health services provider's stock worth $932,000 after purchasing an additional 63,028 shares during the period. Point72 Asia Singapore Pte. Ltd. increased its stake in shares of Teladoc Health by 194.2% in the 2nd quarter. Point72 Asia Singapore Pte. Ltd. now owns 6,891 shares of the health services provider's stock valued at $67,000 after purchasing an additional 4,549 shares in the last quarter. Finally, SG Americas Securities LLC raised its position in Teladoc Health by 41.2% during the third quarter. SG Americas Securities LLC now owns 76,891 shares of the health services provider's stock worth $706,000 after acquiring an additional 22,424 shares during the period. Hedge funds and other institutional investors own 76.82% of the company's stock.

Insider Activity at Teladoc Health

In other news, insider Carlos Nueno sold 2,389 shares of the stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the transaction, the insider now directly owns 2,890 shares in the company, valued at $34,477.70. This represents a 45.25 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.95% of the stock is owned by corporate insiders.

Teladoc Health Trading Up 5.7 %

NYSE TDOC traded up $0.60 during trading hours on Wednesday, hitting $11.00. The company's stock had a trading volume of 7,355,752 shares, compared to its average volume of 4,122,434. Teladoc Health, Inc. has a twelve month low of $6.76 and a twelve month high of $21.74. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The firm has a market capitalization of $1.89 billion, a P/E ratio of -1.91 and a beta of 1.04. The stock has a fifty day moving average of $10.01 and a 200 day moving average of $9.09.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on TDOC. Oppenheimer reduced their target price on shares of Teladoc Health from $14.00 to $12.00 and set an "outperform" rating for the company in a research report on Friday, January 24th. Royal Bank of Canada increased their price target on Teladoc Health from $11.00 to $12.00 and gave the stock an "outperform" rating in a report on Friday, January 24th. Evercore ISI upped their price target on Teladoc Health from $8.00 to $9.00 and gave the stock an "in-line" rating in a research note on Tuesday, October 8th. The Goldman Sachs Group started coverage on shares of Teladoc Health in a research note on Friday, November 15th. They set a "buy" rating and a $14.00 target price on the stock. Finally, Piper Sandler reiterated an "overweight" rating and issued a $13.00 price objective (up previously from $11.00) on shares of Teladoc Health in a research note on Wednesday, December 4th. Fourteen research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $12.08.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.